Autoimmune Diseases Stem Cell Protocol
Systemic Immunomodulation & Inflammation Management Route
- Starting Price: $7,000 USD (Preliminary Planning Estimate)
- Location: Cali, Colombia
- Suggested Stay: 4 Days
- Administration: Systemic Intravenous (IV) Infusion
- Product & Dose: Umbilical Cord-Derived Mesenchymal Stem Cells (TRUSTEM BANK)
- Regulatory Status: Investigational Intervention
Important Medical Notice:
Cell therapy for autoimmune conditions is an investigational pathway focused on systemic immunomodulation and inflammatory markers evaluation. It must not be presented as a cure, guaranteed lifelong remission, replacement for essential immunosuppressants without specialist approval, or absolute disease reversal.
Institutional Provider Details:
Legal Entity: STEM CELLS KYRON COLOMBIA SCKC
Facility Address: Calle 6 Oeste #24f-13, Cali, Colombia
Medical Director: Dr. Carlos Eduardo Rojas Martínez, MD (CEO)
Cell Processing Laboratory: TRUSTEM BANK
Clinical Patient Manager: Daniel Sanz
SCOPE OF SERVICE
(INCLUSIONS & EXCLUSIONS)
Included in the Package
- Pre-travel medical record & laboratory history review
- On-site medical consultation & physical examination in Cali
- Protocol-defined baseline diagnostic testing
- Cellular product explanation & laboratory quality reports
- Systemic IV administration & post-infusion clinical monitoring
- Medical discharge summary for your home rheumatologist/physician
- Structured remote follow-up at Weeks 4, 14, 36, and 52
Exclusions & Out-of-Pocket Expenses
- Flights, passports, visas, lodging, & daily meals
- Local transfers, travel insurance, & emergency evacuation
- Unscripted specialty consultations or extended hospital stays
- Physical therapy, weight management, or ongoing rehab programs
- Emergency room care or unscripted complication treatments
- Repeat procedures or unquoted protocol adjustments
- Caregiver expenses or personal travel companions
CLINICAL ELIGIBILITY & REQUIRED DOCUMENTS
Potential Candidates for Evaluation:
Adults with confirmed autoimmune conditions evaluated for systemic inflammation management.
Documented disease stability and comprehensive diagnostic workup from a home specialist.
Ability to provide informed consent and adhere to follow-up protocols.
Realistic expectations acknowledging that complete cure or medication elimination cannot be guaranteed.
Situations Requiring Additional Evaluation or Exclusion:
Active systemic infection, sepsis, severe leukopenia, or acute flare-up requiring emergency care.
Severe uncompensated organ failure (renal, hepatic, cardiac, or respiratory).
Active malignancy or history of recent unmonitored oncological disease.
Severe bleeding disorders, active thrombosis, or known severe allergies to protocol reagents.
Pregnancy or lactation.
Detailed medical history documenting disease duration, systemic involvement, and flare frequency.
Complete list of current medications, biologics, immunosuppressants, steroids, and dosages.
Recent laboratory reports: CBC, ESR, CRP, renal/liver function, and disease-specific antibody panels.
Recent organ-specific workups (ECG, chest X-ray/CT, or ultrasound) when clinically applicable.
Contact details for your treating home rheumatologist or primary care physician.
PROTOCOL SPECS & 4-DAY TIMELINE
Cellular Product Specifications:
Cell Type: Umbilical Cord-Derived Mesenchymal Stem Cells (UC-MSCs).
Manufacturing Laboratory: TRUSTEM BANK.
Dose & Route: Protocol-adjusted dosage delivered via Systemic Intravenous (IV) Infusion.
Quality Assurance: Certificate of analysis verifying cell viability, sterility, endotoxin, and mycoplasma testing.
4-Day Clinical Itinerary:
Pre-Travel (1 Week Prior): File review, clinical pre-selection, and budget approval.
Day 1 (Arrival in Cali): On-site clinical assessment, medical consultation, and baseline labs.
Day 2 (Procedure Day): IV infusion procedure and structured clinical post-infusion monitoring.
Day 3 (Local Observation): Vital signs tracking, systemic symptom monitoring, and local observation.
Day 4 (Travel Clearance): Final medical evaluation, discharge summary, and return travel clearance.
Remote Follow-Up: Scheduled tracking calls at Weeks 4, 14, 36, and 52.
POST-PROCEDURE RECOVERY & RISK DISCLOSURE
Post-Procedure Recovery Guidelines:
First 24–48 Hours: Stay hydrated and rest. Report any fever, chills, rash, breathlessness, or unusual fatigue immediately.
First Month: Continue all prescribed home immunosuppressive or disease-modifying medications unless explicitly altered by your primary rheumatologist.
General Risks and Possible Complications:
Transient low-grade fever, mild headache, nausea, or localized vein irritation at the IV site.
Temporary inflammatory response or fatigue.
Rare allergic, infusional, or vascular complications.
Absence of clinical response or financial risk.
FREQUENTLY ASKED QUESTIONS
1. Is cell therapy an approved cure for autoimmune diseases?
No. It is an investigational route focused on immunomodulative pathways, not a guaranteed cure.
2. Should I stop my prescribed immunosuppressants before traveling?
No. Never alter or stop your prescribed autoimmune medications or steroids without direct clearance from your home medical team.
3. How are the cells delivered?
They are administered through a controlled systemic intravenous (IV) infusion.
4. What does the $7,000 USD starting price cover?
It covers pre-travel review, medical consultations in Cali, baseline tests, cell product, administration, and 12-month remote tracking.
PRE-DECISION CHECKLIST
- I understand that cell therapy for autoimmune conditions is investigational.
- I know the cell source (UC-MSCs), administration route (IV), and quality certificates.
- I have shared my full medical history, biologic medications, and recent lab results.
- I understand that I must not stop my regular medications without specialist guidance.
- I have consulted my home physician/rheumatologist prior to planning my trip.
Share your diagnostic history and current treatment list to determine your eligibility for our systemic immunomodulation route.
+ (1) 305 400 1476
+ (57) 315 399 5608
